China's healthcare sector is making steady progress in opening up to foreign investment and expertise, with more than 150 joint-venture and wholly overseas-invested medical institutions now operating nationwide, a senior health official announced Monday.

The 2024 annual reports of major Chinese IVD companies released.

LGC announced today that it has acquired SeraCare Life Sciences, a provider of quality control materials for the infectious disease testing and next-generation sequencing markets. According to LGC, the acquisition strengthens the firms posit

Stilla Technologies announced today that it has completed a 16 million ($18.3 million) Series A financing round led by Illumina Ventures. Kurma Partners, LBO France, BNP Paribas Dveloppement, Paris Saclay Seeds, and Idinvest Partners also pa

Agilent Technologies reported after the close of the market on Monday that its fourth quarter revenues grew 9 percent year over year. For the three months ended Oct. 31, the life sciences company said total revenues rose to $1.29 billion fro

The global genotyping market is projected to reach USD 31.9 billion by 2023 from USD 11.8 billion in 2018, at a CAGR of 22.0%. This study involved the extensive use of both primary and secondary sources. The research process involved the stu

BioMrieux, the international leader in in vitro diagnostics, today announced the acquisition of a controlling stake in Suzhou Hybiome Biomedical Engineering Co. Ltd. The company announced in July 2018 that it had acquired a minority stake in

NEW YORK (GenomeWeb) Illumina plans to acquire Pacific Biosciences for approximately $1.2 billion in cash, the companies said on Thursday. Under the agreement, which has been approved by both companies boards of directors, Illumina will pay

This story has been amended to correct errors and remove references to unrelated legal cases. NEW YORK (GenomeWeb) A jury has awarded Bio-Rad Laboratories $23.9 million in damages in the firms patent infringement suit against 10x Genomics,

Bionano Genomics reported a 3 percent increase in third-quarter revenues after the market close recently . Fresh off its initial public offering in August , in which it raised $23.7 million in gross proceeds, the San Diego-based DNA analysi

PerkinElmer Genomics has chosen BioDiscoverys NxClinical software for genomic data analysis for its services, BioDiscovery announced recently . The software will enable PerkinElmer Genomics to provide fast and accurate copy number variation

The global Point of Care (POC) hematology diagnostics market is expected to grow at a CAGR of close to 9% over the forecast period 2018-2022 to reach a value of USD 2.7 billion by 2022, driven mainly by the rising prevalence of hematology co